更多...
收起
Overexpression of the TCL1 gene in humans has been implicated in the development of mature T cell leukemia, in which chromosomal rearrangements bring the TCL1 gene in close proximity to the T-cell antigen receptor (TCR)-alpha (MIM 186880) or TCR-beta (MIM 186930) regulatory elements (summarized by Virgilio et al., 1998 [PubMed 9520462]). In normal T cells TCL1 is expressed in CD4-/CD8- cells, but not in cells at later stages of differentiation. TCL1 functions as a coactivator of the cell survival kinase AKT (MIM 164730) (Laine et al., 2000 [PubMed 10983986]).[supplied by OMIM, Jul 2010]
[中文简述(自动翻译):]  人类中TCL1基因的过表达已在成熟T细胞白血病的发展,其中,染色体重排使TCL1基因在接近T细胞抗原受体(TCR)-α-牵连(MIM 186880)或TCR-β(MIM 186930)的调节元件(由维尔吉利奥等人,1998年[搜索PubMed 9520462]总结)。在正常的T细胞TCL1在CD4- / CD8-细胞中表达,但不能在分化的后期阶段的细胞。 TCL1用作细胞存活激酶AKT的共活化剂(MIM 164730)(莱恩等人,2000 [搜索PubMed 10983986])。[由OMIM,2010年7月供给]
TCL1A基因(以及对应的蛋白质)的细胞分布位置:
TCL1A基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Chronic Lymphocytic Leukemia | 0.020659377 | 47 | 0 | BeFree_LHGDN |
Lymphoma | 0.016054797 | 23 | 0 | BeFree_LHGDN |
Leukemia, T-Cell | 0.014667793 | 45 | 0 | BeFree_LHGDN |
leukemia | 0.008153188 | 21 | 0 | BeFree_LHGDN |
T-Cell Prolymphocytic Leukemia | 0.006795978 | 15 | 0 | BeFree_LHGDN |
B-Cell Lymphomas | 0.006253095 | 14 | 0 | BeFree_LHGDN |
Leukemia, T-Cell, Chronic | 0.003257302 | 12 | 0 | BeFree |
Bacterial Infections | 0.00272435 | 1 | 0 | LHGDN |
Heart failure | 0.002638474 | 1 | 3 | BeFree_GAD |
Animal Mammary Neoplasms | 0.002367032 | 1 | 0 | GAD |
Tobacco Use Disorder | 0.002367032 | 1 | 0 | GAD |
Mammary Neoplasms | 0.002367032 | 1 | 0 | GAD |
Ataxia Telangiectasia | 0.002171535 | 8 | 0 | BeFree |
Leukemogenesis | 0.001900093 | 7 | 0 | BeFree |
Prolymphocytic Leukemia | 0.001357209 | 5 | 0 | BeFree |
Adult T-Cell Lymphoma/Leukemia | 0.001357209 | 5 | 0 | BeFree |
Diffuse Large B-Cell Lymphoma | 0.001357209 | 5 | 0 | BeFree |
Burkitt Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Congenital chromosomal disease | 0.000542884 | 2 | 0 | BeFree |
Lymphoid leukemia | 0.000542884 | 2 | 0 | BeFree |
Acute lymphocytic leukemia | 0.000542884 | 2 | 0 | BeFree |
Leukemia, Myelocytic, Acute | 0.000542884 | 2 | 0 | BeFree |
Lymphoproliferative Disorders | 0.000542884 | 2 | 0 | BeFree |
Multiple Myeloma | 0.000542884 | 2 | 0 | BeFree |
Peripheral T-Cell Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Lymphoma, AIDS-Related | 0.000542884 | 2 | 0 | BeFree |
Epstein-Barr Virus Infections | 0.000542884 | 2 | 0 | BeFree |
Isochromosomes | 0.000542884 | 2 | 0 | BeFree |
Splenic Marginal Zone B-Cell Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of breast | 0.000271442 | 1 | 0 | BeFree |
Fatigue | 0.000271442 | 1 | 0 | BeFree |
Congestive heart failure | 0.000271442 | 1 | 0 | BeFree |
Hepatomegaly | 0.000271442 | 1 | 0 | BeFree |
Angioimmunoblastic Lymphadenopathy | 0.000271442 | 1 | 0 | BeFree |
Immunologic Deficiency Syndromes | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, Follicular | 0.000271442 | 1 | 0 | BeFree |
Neoplasm Metastasis | 0.000271442 | 1 | 0 | BeFree |
Seminoma | 0.000271442 | 1 | 0 | BeFree |
T-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Spastic syndrome | 0.000271442 | 1 | 0 | BeFree |
childhood small noncleaved cell lymphoma | 0.000271442 | 1 | 0 | BeFree |
Solid tumour | 0.000271442 | 1 | 0 | BeFree |
Lymphoid hyperplasia | 0.000271442 | 1 | 0 | BeFree |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.000271442 | 1 | 0 | BeFree |
Hyperplastic lymph node | 0.000271442 | 1 | 0 | BeFree |
Disseminated Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Hematologic Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Carcinogenesis | 0.000271442 | 1 | 0 | BeFree |
Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cardiomyopathies | 0.000271442 | 1 | 0 | BeFree |
Primary cutaneous B-cell lymphoma | 0.000271442 | 1 | 0 | BeFree |
Chronic leukemia (category) | 0.000271442 | 1 | 0 | BeFree |
Primary Effusion Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Mediastinal (Thymic) Large B-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Hepatosplenic T-cell lymphoma | 0.000271442 | 1 | 0 | BeFree |
Precursor Lymphoid Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Hepatocarcinogenesis | 0.000271442 | 1 | 0 | BeFree |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Liver carcinoma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。